Skip to content
  • Sunday, 26 July 2026
  • 1:46 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • MIT Researchers Identify Genetic Pathway Linking Gene Mutation to Cognitive Disconnect in Schizophrenia
Neuroscience & Brain Research

MIT Researchers Identify Genetic Pathway Linking Gene Mutation to Cognitive Disconnect in Schizophrenia

Rifan Muazin May 2, 2026 0

A groundbreaking study led by researchers at the Massachusetts Institute of Technology (MIT) has identified a specific genetic mutation and…

Read More
Neuroscience & Brain Research

MIT Researchers Identify Genetic Pathway and Brain Circuitry Linked to Cognitive Impairment in Schizophrenia

Rifan Muazin Apr 18, 2026 0

Schizophrenia remains one of the most complex and debilitating psychiatric disorders, affecting approximately 24 million people worldwide. While the condition…

Read More
Neuroscience & Brain Research

MIT Researchers Identify Genetic Mutation Linked to Schizophrenia and Cognitive Dysfunction

Rifan Muazin Apr 11, 2026 0

A breakthrough study led by neuroscientists at the Massachusetts Institute of Technology (MIT) has identified a specific genetic mutation that…

Read More
Neuroscience & Brain Research

MIT Researchers Identify Genetic Mutation Linked to Cognitive Impairment in Schizophrenia

Rifan Muazin Apr 3, 2026 0

Schizophrenia remains one of the most complex and debilitating neurological conditions, affecting approximately one percent of the global population. While…

Read More
TWiV 1286: Clinical update with Dr. Daniel GriffinRevolutionizing Local AI: Fine-Tuning Language Models on Apple Silicon with MLXBreath-based VOC Analysis Offers Faster, Non-invasive Assessment of Gut Microbiome Health and Earlier Disease DetectionWHO Introduces Faster, More Accessible TB Testing Strategies While CDC Maintains a Targeted, Risk-Based Approach in the United States.
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ